Skip to content

Thursday, October 15, 2026

Top Stories Global Economy Markets Topics & Series Contributors Opinion

All desks ⌄

Economy & Finance

Economy Investing Central Banks Digital Currency Fintech Research & Analysis Technicals

Power & Business

Politics Business Law Insights & Views Governance Market Roundups

Science & Society

Technology Science Nature Health Life

In focus · trending topic

orphan exclusivity

1 stories · following the connections

EconoTimes — Reading the Times. Understanding the Future.

FDA Recognizes Orphan Drug Exclusivity for Adamas’ GOCOVRI™

By Nasdaq OMXOct 25, 2017, 4:31 PM UTC

←1→Page 1 of 1

Connected markets

Follow the indicators behind the story.

Illustrative data · 06 Oct 2026, 08:00 UTC

Keep exploring

Telecommunications Artificial Intelligence Huawei Cybersecurity Solana Circle USD Coin Stablecoins

Coverage

Global Economy Markets Technology Politics All news

Intelligence

Topics & Series Contributors Research

Company

About us Become a contributor Contact Editorial standards

© 2026 PUBLISH Holdings LLC.Privacy Terms of use Our standards

Home Markets Topics Search